A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients with COVID-19
Criteria:Tested positive for COVID-19 within the last 5 days
Must be High Risk;
>65 years old; Must have one of the following; Obesity, Diabetes, Cardiovacular Disease, Chronic lung disease
>80 years old; no other requirements